pain relief in patients with upper abdominal cancers

Comparative study between pulsed Radiofrequency ablation and continuous Radiofrequency ablation of splanchnic Plexus for pain relief in patients with upper abdominal cancers

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/035243

Enrollment

Registered

2021-07-29

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C23- Malignant neoplasm of gallbladder Health Condition 2: C259- Malignant neoplasm of pancreas, unspecified Health Condition 3: C169- Malignant neoplasm of stomach, unspecified

Interventions

Intervention1: Pulsed radio-frequency ablation and continuous radio-frequency ablation: VAS score of patients receiving pulsed radio-frequency ablation and continuous radio-frequency ablation is compa

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from upper abdominal cancer pain. Patients of age group 10-80 yrs. of age Patients with visceral pain with visual analogue pain score Ã¢â?°Â¥ 4. Patients with normal coagulation profile. Patients with positive diagnostic test. Patients who give written and informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with organ failure. 2.Patients 80yrs. 3.Patients with coagulation disorders. 4.Patients with local infection at the puncture site or sepsis. 5.Patients with allergy to the contrast dye. 6.Patients with severe displacement of intra-abdominal structures. 7.Pregnant women. 8.Patients with psychiatric illness affecting cooperation. 9.Patients with de-compensated cardiac disorders. 10.Patients with liver and renal dysfunction 11.Patients who do not give consent.

Design outcomes

Primary

Measure	Time frame
Pain relief by Visual analogue pain scaleTimepoint: Pain relief [ Time Frame:15days, 1month, 3months, 6 months]	—

Secondary

Measure	Time frame
1.Quality of life assessed bg Edmonton Scale 2.Decrease the need for analgesic drugs 3.Reduction of total oral morphine consumption dose in mg per day. Timepoint: Quality of life [Time Frame:15 days, 1month, 3months, 6 months] Edmonton Scale 2.Decrease the need for analgesic drugs [ Time Frame:15days, 1month, 3months, 6 months] Reduction of total oral morphine consumption dose in mg per day.	—

Countries

India

Contacts

Public ContactSarita Singh

King Georges Medical University Lucknow

saritacsmmu@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026